Business · 15/09/2017Updated: 10/17/2026 · 1 min read
FDA Renews Nonprescription Drugs Advisory Committee Charter for 2 Years
Summary
The FDA has renewed the Nonprescription Drugs Advisory Committee charter for an additional 2 years, with the new term set to expire on August 27, 2019, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →